CVS

In the past six months (April 2026 - October 2026), CVS Health's stock trended upwards by 9.28%. In May 2026, the company reported strong first-quarter results with a 6.2% year-over-year revenue increase, raising its full-year guidance, driven by growth across all segments despite pharmacy reimbursement pressure and business investments. S&P Global Ratings revised CVS Health's outlook to stable from negative in May 2026. In October 2026, CVS Health's Medicare Advantage Star ratings for 2027 were weaker than expected, with 70% of MA enrollment in 4-star plans, down from 81% in 2026, anticipating a financial impact of approximately $720 million in 2028, leading to some stock dips. Throughout 2026, the company's exit from the individual exchange business resulted in a decrease of approximately 600 thousand medical members by March 31, 2026.